These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2838848)

  • 1. Cytoplasmic domain affects membrane expression and function of an Ia molecule.
    Griffith IJ; Ghogawala Z; Nabavi N; Golan DE; Myer A; McKean DJ; Glimcher LH
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4847-51. PubMed ID: 2838848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure-function relationship of I-A molecules: a biochemical analysis of I-A polypeptides from mutant antigen-presenting cells and evidence of preferential association of allelic forms.
    Schlauder GG; Bell MP; Beck BN; Nilson A; McKean DJ
    J Immunol; 1985 Sep; 135(3):1945-54. PubMed ID: 3874910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ek beta mutant antigen-presenting cell lines expressing altered Ak alpha molecules.
    Quill H; Schwartz RH; Glimcher LH
    J Immunol; 1986 May; 136(9):3351-9. PubMed ID: 3082986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of a non-polymorphic residue in a class II E beta gene eliminates an antibody-defined epitope without affecting T cell recognition.
    Griffith IJ; Carland FM; Glimcher LH
    J Immunol; 1987 Jun; 138(12):4480-3. PubMed ID: 2438346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single base mutation in an I-A alpha-chain gene alters T-cell recognition.
    Griffith IJ; Choi EM; Glimcher LH
    Proc Natl Acad Sci U S A; 1987 Feb; 84(4):1090-3. PubMed ID: 3493486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen presentation abrogated in cells expressing truncated Ia molecules.
    Nabavi N; Ghogawala Z; Myer A; Griffith IJ; Wade WF; Chen ZZ; McKean DJ; Glimcher LH
    J Immunol; 1989 Mar; 142(5):1444-7. PubMed ID: 2918224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional sites on the A alpha-chain. Polymorphic residues involved in antigen presentation to insulin-specific, Ab alpha:Ak beta-restricted T cells.
    Reske-Kunz AB; Landais D; Peccoud J; Benoist C; Mathis D
    J Immunol; 1989 Sep; 143(5):1472-81. PubMed ID: 2474599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Exon-shuffling" maps control of antibody- and T-cell-recognition sites to the NH2-terminal domain of the class II major histocompatibility polypeptide A beta.
    Germain RN; Ashwell JD; Lechler RI; Margulies DH; Nickerson KM; Suzuki G; Tou JY
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2940-4. PubMed ID: 3921966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. I-A-restricted T cell antigen recognition. Analysis of the roles of A alpha and A beta using DNA-mediated gene transfer.
    Lechler RI; Ronchese F; Braunstein NS; Germain RN
    J Exp Med; 1986 Mar; 163(3):678-96. PubMed ID: 2419471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IA mutant functional antigen-presenting cell lines.
    Glimcher LH; Hamano T; Asofsky R; Sachs DH; Pierres M; Samelson LE; Sharrow SO; Paul WE
    J Immunol; 1983 May; 130(5):2287-94. PubMed ID: 6300242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
    Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
    J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of antigen presentation to T cell hybridomas by purified Ia molecules in planar membranes. Ia molecule polymorphism determines the antigenic fine specificity of the response to cytochrome c peptides.
    Quill H; Carlson L; Fox BS; Weinstein JN; Schwartz RH
    J Immunol Methods; 1987 Apr; 98(1):29-41. PubMed ID: 2435810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional effects of N-linked oligosaccharides located on the external domain of murine class II molecules.
    Wei BY; Buerstedde JM; Bell M; Chase C; Nilson A; Browne A; Pease L; McKean DJ
    J Immunol; 1991 Apr; 146(7):2358-66. PubMed ID: 1706396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of murine MHC class II molecule expression. Identification of A beta residues responsible for allele-specific cell surface expression.
    Buerstedde JM; Pease LR; Nilson AE; Bell MP; Chase C; Buerstedde G; McKean DJ
    J Exp Med; 1988 Sep; 168(3):823-37. PubMed ID: 3049906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I-Ak polymorphisms define a functionally dominant region for the presentation of hen egg lysozyme peptides.
    Rosloniec EF; Vitez LJ; Beck BN; Buerstedde JM; McKean DJ; Landais D; Benoist C; Mathis D; Freed JH
    J Immunol; 1989 Jul; 143(1):50-8. PubMed ID: 2786533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function analysis of the Abm12 beta mutation using site-directed mutagenesis and DNA-mediated gene transfer.
    Ronchese F; Brown MA; Germain RN
    J Immunol; 1987 Jul; 139(2):629-38. PubMed ID: 3110276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell recognition of Ia molecules selectively altered by a single amino acid substitution.
    Brown MA; Glimcher LA; Nielsen EA; Paul WE; Germain RN
    Science; 1986 Jan; 231(4735):255-8. PubMed ID: 3484558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic and functional characterization of a panel of antigen-presenting cell lines expressing mutant I-A class II molecules.
    Glimcher LH; Sharrow SO; Paul WE
    J Exp Med; 1983 Nov; 158(5):1573-88. PubMed ID: 6195287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and molecular characterization of I-A kappa beta mutants is consistent with the predicted three dimensional structure of class II MHC molecules.
    Brown MA; Griffith IJ; Glimcher LH
    Mol Immunol; 1990 Jul; 27(7):645-50. PubMed ID: 2395436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo treatment with monoclonal anti-I-A antibodies: disappearance of splenic antigen-presenting cell function concomitant with modulation of splenic cell surface I-A and I-E antigens.
    Kruisbeek AM; Titus JA; Stephany DA; Gause BL; Longo DL
    J Immunol; 1985 Jun; 134(6):3605-14. PubMed ID: 2580891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.